Margin issue to be renegotiated

The Pharmaceutical Development Consultative Committee says it will have a meeting with GlaxoSmithKline until April 23 over the controversial wholesaler margin issue, while distributing all of GSK medicines on a conditional basis

In a April 14 meeting with a high-ranking GSK official, which was organized by the Korean Pharmaceutical Association, representatives from the Korea Association of P...